Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Vitamin A deficiency induces sex-specific reward processing alterations through a dysregulation of the mesolimbic dopamine transmission in mice
    Published on 2026-04-04
    4 months ago
  • Trajectories of late-life depression: insights from molecular imaging
    Published on 2026-04-01
    4 months ago
  • Reply to mol: Comparing apples and oranges in TRD treatment: the importance of assumptions in network meta-analysis
    Published on 2026-03-31
    4 months ago
  • Comparing apples and oranges in TRD treatment: the importance of assumptions in network meta-analysis
    Published on 2026-03-31
    4 months ago
  • Correction: ACNP 64th Annual Meeting: Panels, Mini-Panels and Study Groups
    Published on 2026-03-26
    4 months ago
  • MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats
    Published on 2026-03-26
    4 months ago
  • It’s not all DAT: harnessing the potential of organic cation transporter 3 inhibition to selectively attenuate amphetamine reinforcement and dopamine release
    Published on 2026-03-25
    4 months ago
« Previous 1 … 15 16 17 18 19 … 143 Next »
Journal of Psychopharmacology
  • Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
    Published on 2025-12-04
    8 months ago
  • The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications
    Published on 2025-12-02
    8 months ago
  • The role of psychopharmacology and cognitive neuroscience in understanding the brain in the treatment of psychiatric disorders and neurological diseases for the benefit of society
    Published on 2025-12-01
    8 months ago
  • “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS
    Published on 2025-12-01
    8 months ago
  • A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia
    Published on 2025-12-01
    8 months ago
  • Psychedelic research – Going global
    Published on 2025-12-01
    8 months ago
  • (-)-OSU6162 reduces freezing elicited by context-conditioned fear in rats
    Published on 2025-11-29
    8 months ago
« Previous 1 … 15 16 17 18 19 … 150 Next »
European Neuropsychopharmacology
  • Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach
    Published on 2025-11-26
    8 months ago
  • Editorial Board
    Published on 2025-11-25
    8 months ago
  • Three shades of gloom: investigating the genetic background of current depressive symptoms associated with different severity of current stress exposure in a general population
    Published on 2025-11-24
    8 months ago
  • Reply to the commentary on “Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”
    Published on 2025-11-23
    8 months ago
  • Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer’s disease, obesity and type 2 diabetes
    Published on 2025-11-22
    8 months ago
  • Patterns, predictors and outcomes of trajectories for subjective quality of life in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention
    Published on 2025-11-22
    8 months ago
  • Persistent mortality gap in schizophrenia: current challenges and future directions
    Published on 2025-11-22
    8 months ago
« Previous 1 … 15 16 17 18 19 … 168 Next »

   Pharma Pub